Last reviewed · How we verify
NCT06763575
Efficacy of Surgical Glove-Compression Therapy As a Prevention of Paclitaxel-Induced Peripheral Neuropathy
NA trial testing Surgical Glove-Compression Therapy in Paclitaxel-induced Peripheral Neuropathy in 36 participants. Currently enrolling.
1 January 2026
Quick facts
| Lead sponsor | Department of Medical Services Ministry of Public Health of Thailand |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 36 |
| Start date | 1 January 2025 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 June 2026 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Surgical Glove-Compression Therapy
- non-compressive plastic gloves
Conditions studied
- Paclitaxel-induced Peripheral Neuropathy — all drugs for Paclitaxel-induced Peripheral Neuropathy →
Sponsor
Department of Medical Services Ministry of Public Health of Thailand
Who can join
18 and older, any sex, with Paclitaxel-induced Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this randomized controlled trial (RCT) is to compare the incidence of paclitaxel-induced grade 2 or higher sensory peripheral neuropathy, evaluated using the CTCAE version 5.0, between patients receiving surgical glove-compression therapy (SGCT) and those in the control group. The main question is whether SGCT is effective in preventing paclitaxel-induced sensory peripheral neuropathy. * Intervention group: receive SGCT. * Control group: receive non-compressive plastic gloves.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06763575
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Paclitaxel-induced Peripheral Neuropathy
Currently open trials in the same condition.
- NCT06964802 — The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy · NA · recruiting
Other Department of Medical Services Ministry of Public Health of Thailand trials
Trials by the same sponsor.
- NCT06665737 — Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients · Phase 4 · not yet recruiting
- NCT06860659 — Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient With Moderate to Severe Dry Eye · Phase 4 · enrolling by invitation
- NCT06525870 — Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Control · Phase 2 · enrolling by invitation
- NCT06436833 — Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Gl · NA · recruiting
- NCT04589364 — Study of Abobotulinum Toxin Versus Neubotulinum Toxin Injection For Hemifacial Spasm in Thai Patients · Phase 3 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06763575 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Department of Medical Services Ministry of Public Health of Thailand
- Last refreshed: 8 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06763575.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing